Table 2. PFAA values (μmol/L) for patients with PC and healthy controls in the training set.
| PFAA | HC (N = 600) | PC (N = 120) | |
|---|---|---|---|
| Mean±SD (range) | Mean±SD (range) | p-value* | |
| Thr | 121.5 ± 24.3 (74.8–257.6) | 112.8 ± 30.3 (54.2–215.5) | <0.001 |
| Ser | 109.1 ± 17.1 (47.9–177.6) | 119.2 ± 22.5 (68.6–189.3) | <0.0001 |
| Asn | 45.4 ± 7.1 (28.6–94.6) | 41.1 ± 7.4 (20.0–64.9) | <0.0001 |
| Gln | 575.2 ± 61.6 (327.6–787.1) | 566.3 ± 87.0 (342.2–854.6) | ≥0.1 |
| Pro | 141.4 ± 45.4 (57.1–360.8) | 129.9 ± 36.1 (56.6–266.7) | <0.05 |
| Gly | 213.2 ± 53.1 (123.4–461.5) | 219.1 ± 64.1 (102.5–515.3) | ≥0.1 |
| Ala | 351.5 ± 72.2 (196.8–577.4) | 296.5 ± 70.7 (157.0–517.7) | <0.0001 |
| Cit | 32.4 ± 6.9 (14.7–66.5) | 28.5 ± 8.7 (9.8–51.5) | <0.0001 |
| Val | 220.9 ± 38.7 (126.6–358.3) | 200.1 ± 42.9 (91.4–308.0) | <0.0001 |
| Met | 25.9 ± 4.7 (16.0–70.1) | 23.4 ± 5.4 (13.0–42.5) | <0.0001 |
| Ile | 61.4 ± 13.8 (32.0–117.0) | 63.2 ± 14.6 (30.1–109.3) | ≥0.1 |
| Leu | 119.6 ± 22.4 (67.2–203.1) | 111.6 ± 25.2 (47.1–188.9) | <0.01 |
| Tyr | 65.5 ± 12.1 (25.7–117.2) | 58.9 ± 13.0 (33.3–103.3) | <0.0001 |
| Phe | 59.1 ± 8.0 (32.7–95.8) | 57.2 ± 8.7 (34.8–84.2) | <0.01 |
| His | 80.3 ± 9.4 (51.6–120.7) | 67.3 ± 11.9 (41.1–103.7) | <0.0001 |
| Trp | 56.7 ± 9.0 (10.6–88.9) | 47.4 ± 10.1 (9.6–71.7) | <0.0001 |
| Orn | 53.6 ± 11.8 (25.1–136.1) | 51.8 ± 15.6 (22.3–109.9) | ≥0.1 |
| Lys | 192.3 ± 27.3 (118.9–276.1) | 177.1 ± 39.7 (78.4–320.1) | <0.0001 |
| Arg | 94.2 ± 15.9 (50.3–149.0) | 85.9 ± 22.3 (41.7–156.9) | <0.0001 |
*p values were calculated using the Mann–Whitney U-test.